FOI request 1810 – Pre-PBAC evaluation of AJOVY(fremanezumab)

The information released on this page contains the documents concerning the pre-PBAC evaluation of AJOVY (fremanezumab) at the November 2019 meeting


Additional Analysis 1

Summary of Estimated Patients 1

Additional Analysis 2

Fremanezumab commentary

TAG CER for Fremanezumab

Summary of Estimated Patients 3

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

FOI number:
FOI release date:
Publication type:
General public

This request summaries and commentary about the pre-PBAC evaluation of AJOVY (fremanezumab)

Help us improve

If you would like a response please use the enquiries form instead.